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Abstract
Background: Gallbladder cancer is the most common malignancy of the biliary tract. Radical surgery
(including liver resection and regional lymphadenectomy) is applied for some gallbladder cancers, but the
benefits of these procedures are unproven. For patients with T1b cancers discovered incidentally on
cholecystectomy specimens, the utility of radical surgery remains debated.
Methods: A decision analytic Markov model was created to estimate and compare life expectancy
associated with management strategies for a simulated cohort of patients with incidentally discovered
T1b gallbladder cancer after routine cholecystectomy. In one strategy, patients were treated with no
additional surgery; in another, patients were treated with radical resection. The primary (base-case)
analysis was calculated based on a cohort of 71-year-old females and incorporated best available input
estimates of survival and surgical mortality from the literature. Sensitivity analysis was performed to
assess the effects of model uncertainty on outcomes.
Results: In the base-case analysis, radical resection was favoured over no further surgical resection,
providing a survival benefit of 3.43 years for patients undergoing radical resection vs. simple cholecys-
tectomy alone. Sensitivity analysis on the age at diagnosis demonstrated that the greatest benefit in
gained life-years was achieved for the youngest ages having radical resection, with this benefit gradually
decreasing with increasing age of the patient. High peri-operative mortality rates (36%) led to a change
in the preferred strategy to simple cholecystectomy alone.
Conclusions: Decision analysis demonstrates that radical resection is associated with increased sur-
vival for most patients with T1b gallbladder cancer.
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Introduction
Gallbladder cancer is the most common malignancy of the biliary
tract.1 Curative surgical resection remains the best method for
achieving long-term survival. There is considerable debate as to
whether T1b gallbladder cancers (tumour invading into, but not
through, the muscularis propria) are best treated by simple chole-
cystectomy alone or by radical resection (including liver resection
and regional lymphadenectomy).2,3 Although some authors
suggest that simple cholecystectomy is sufficient,1,4–9 others advo-
cate radical resection.3,10–17
Because of the low incidence of gallbladder cancer, it is unlikely
that controlled clinical trials that would resolve this debate will
ever be conducted.
Decision analysis provides an ideal method for assessing treat-
ment paradigms for the management of T1b gallbladder cancer,
enabling incorporation of risks and benefits of each strategy. In
this study, the survival benefit of radical gallbladder resection was
evaluated using decision-analytic techniques. A decision-analytic
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Markov model was developed to estimate life expectancy associ-
ated with each intervention for a simulated cohort of patients with
incidentally discovered T1b gallbladder cancer found on gallblad-
der specimens. One group had no additional surgery and patients
were observed. In the second group, patients were treated with
radical resection. The stability of results to changes in key param-
eters were evaluated in sensitivity analysis.
Material and methods
Decision tree
A decision-analytic Markov model was developed to estimate life
expectancy for 71-year-old women with T1b gallbladder cancer
(Fig. 1). The primary (base-case) analysis incorporated specified
best available model input estimates. Stability of results over
changes in model estimates was evaluated in secondary (sensitiv-
ity) analysis. The age of 71 was used, as it was the mean age of
diagnosis reported in a recently published study of over 4000
patients with early-stage gallbladder cancers in the Surveillance,
Epidemiology, and End Results (SEER) tumour registry.18 In this
same study, women comprised the majority of patients with early
gallbladder cancer.18 The model decision tree was constructed and
analysed using software (TreeAge Pro, 2007; TreeAge Software,
Williamstown, MA, USA).
Markov model
The cohorts’ post-treatment life-time course was estimated using
a Markov model with a 1-year cycle length. We constructed this
model in keeping with widely accepted methods for Markov mod-
elling in medicine.19
Patients entered the model after incidental discovery of T1b
gallbladder cancer after or during simple cholecystectomy. Some
patients had no additional surgery, whereas the others were
treated with radical gallbladder resection in a second operation.
Patients in the ‘radical resection’ group were faced with an initial
risk of peri-operative death. Patients in both groups faced poten-
tial cancer-specific mortality each year after diagnosis. Patients in
both groups were also subject to non-cancer mortality.
Model data and data sources
For data collection of probabilities, an initial systematic Medline
search was conducted using the keyword search terms ‘gallbladder
cancer and survival and surgery’ to identify survival data for
patients undergoing surgical treatment for T1b gallbladder cancer.
Upon detailed review of the selected articles and corresponding
references, additional articles were subsequently identified that
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met inclusion criteria. Critical appraisal of each study was per-
formed and studies were selected on the basis of the inclusion
criteria used for this analysis (See Fig. 2).
For the purposes of this study, reviewed publications were
excluded from our analysis if: (i) the number of patients under-
going surgical resection; or (ii) 5-year survival data for those
patients were unavailable.
A second search was conducted using the keywords ‘gallbladder
cancer and perioperativemortality and radical cholecystectomy’ in
order to obtain peri-operative mortality statistics. Representative
studies containing peri-operative mortality for patients undergo-
ing radical resection (not just those for T1b cancers)were included.
Letters, reviews without original data, animal studies, studies
without survival data and overlapping studies were also excluded
from our analysis.
For survival data in the simple cholecystectomy alone group,
data were included regardless if the procedure was performed by
laparoscopic or open technique. In the radical resection group,
survival data were included if the procedure was completed
during the initial operation (cancer discovered intraoperatively)
or if a simple cholecystectomy was performed on the initial opera-
tion and followed at a later date with a more extended resection
(e.g. discovered on pathology reports post-operatively followed by
radical resection). For the radical resection group, we initially
attempted to include only those patients undergoing at least a
wedge resection of the liver bed and regional lymphadenectomy.
However, in a few studies survival data include a few patients who
had undergone less extensive procedures (only a lymphadenec-
tomy and cholecystectomy) or slightly more extensive procedures
(cholecystectomy, liver resection, bile duct resection).
Table 1 Published studies reporting 5-year survival for patients with T1b gallbladder cancers treated with simple cholecystectomy alone
Author Institution Patients 5-year survival
Wagholikar et al.13 Sanjay Gandhi, India 7 57
Cangemi et al.12 University of Rome, Italy 8 37.5
Mizumoto et al.29 Mie University, Japan 9 100
Kim et al.30 Catholic University, Korea 3 100
Wakai et al.9 Niigata University, Japan 13 100
Ouchi et al.31 Miyagi Cancer Cent, Japan 2 50
Principe et al.15 University of Bologna, Italy 1 0
Kwon et al.2 Kansai University, Japan 2 100
Yagi et al.32 Keio University, Japan 1 100
Foster et al.33 Roswell Park, Buffalo, USA 2 50
Cucinotta et al.14 University of Messina, Italy 6 0
Sun et al.8 Yonsei University, Japan 5 100
Nevin et al.34 M.C.V. & Memorial Hosp, USA 5 100
Benoist et al.35 French Cooperative Group 23 74
Shibata et al.36 Oita University, Japan 1 100
Yamamoto et al.37 Kobe University, Japan 15 93a
Goetze et al.23 Multiple centers, Germany 49 45a
Puhalla et al.38 University of Vienna, Austria 5 44a
aCalculated cancer-specific mortality.
Table 2 Published studies reporting 5-year survival for patients with T1b gallbladder cancers treated with radical cholecystectomy
Author Institution Patients 5-year survival
Cangemi et al.12 University of Rome, Italy 3 100
Mizumoto et al.29 Mie University, Japan 3 100
Kim et al.30 Catholic University, Korea 2 100
Wakai et al.9 Niigata University, Japan 7 92
Ouchi et al.31 Miyagi Cancer Cent., Japan 1 100
Shibata et al.36 Oita University, Japan 1 0
Goetze et al.23 Multiple centers, Germany 23 85a
aCalculated cancer-specific mortality.
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In studies that did not explicitly state survival time periods in
the text, we have estimated the survival based on the data given in
tables, text, or presented Kaplan–Meier survival curves.
Peri-operative mortality was defined as death within 30 days
of the surgery. However, in-hospital or operative mortality
(procedure-related) was used as a substitute for peri-operative
mortality when death within 30 days of surgery was not
reported.
Non-cancer-related mortalities were incorporated into the
model using data from the United States Year 2000 Life-Tables.20
Decision analysis models and calculations
Weighted means were calculated for the: (i) 5-year survival for
those patients undergoing simple cholecystectomy; (ii) 5-year sur-
vival for those patients undergoing radical cholecystectomy; and
(iii) peri-operative mortality associated with a radical cholecys-
Table 3 Published studies reporting peri-operative mortality associated with radical resection for gallbladder cancer
Author Institution Patients Periop mortality
Cubertafond et al.39 French Surgical Association 724 22
Tsukada et al.40 First Department of Surgery, Japan 106 0.9
Todoroki et al.41 Institute of Clinical Medicine, Japan 135 3.7
Bartlett et al.42 Memorial Sloan, USA 23 0
Ouchi et al.31 Miyagi Cancer Cent., Japan 4 0
Shirai et al.43 Niigata University, Japan 14 7.1
Fong et al.44 Memorial Sloan, USA 19 5.3
Todoroki et al.41 University of Tsukuba, Japan 135 3.7
Muratore et al.10 Umberto I Mauriziano Hospital, Italy 33 3
Yoshida et al.45 Oita Medical University, Japan 35 0
Suzuki et al.46 Fujimnomiya City General Hospital, Japan 12 0
Mondragon-Sanchez et al.47 Instituto Nacional de Cancerologia, Mexico 20 10
Frena et al.48 Regional Hospital of Bolzano, Italy 20 0
Yamaguchi et al. Kyushu University, Japan 4 0
Onoyama et al.49 Saiseikai Nakatsu Hospital, Japan 32 0
Puhalla et al.38 University of Vienna, Austria 32 6.3
Behari et al.50 Sanjay Gandhi, India 42 4.8
Toyonaga et al.7 Kyushu University, Japan 21 0
Taner et al.51 Mayo Clinic, USA 60 1.7
Yildirim et al.52 Ankara, Turkey 28 0
Foster et al.33 Roswell Park, USA 13 0
Yagi et al.32 Keio University, Japan 47 0
Chan et al.53 University of Hong Kong, China 12 0
Principe et al.15 University of Bologna, Italy 29 0
Benoist et al.35 Hopital Henri-Mondor, France 21 4.8
Schauer et al.5 Ludwig-Maximilian University, Germany 23 0
Cangemi et al.12 Peitro Valdoni, Italy 3 0
Wagholikar et al.13 Sanjay Gandhi, India 2 0
Reddy et al.54 Duke University, USA 22 4.5
Shih et al.28 Johns Hopkins, USA 50 4
Ito et al.55 Brigham and Women's, USA 8 0
Table 4 Study variables
Variable Weighted average (%) Range (%)
5-year survival (simple cholecystectomy) 61.3 0–100
5-year survival (radical cholecystectomy) 87.5 0–100
Perioperative mortality 2 0–6
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tectomy. Weighted means were considered baseline estimates and
were weighted based on the number of patients contributing to
the particular mean.
Calculated 5-year cancer-specific survival probabilities were
converted to 1-year cancer-specific mortality probabilities for use
in the decision-analytic Markov model, using the standard
assumption of an exponential relationship between an event
probability (p) and hazard rate (r) over a specified time period (t),
which can be expressed as p = 1 - e-rt.21,22
For those studies reporting overall (not cancer specific-) sur-
vival, we calculated an adjusted cancer-specific mortality rate uti-
lizing data of female, age-based mortality rates from the United
States Life Tables, 2000.20
Sensitivity analysis
Sensitivity analysis was performed to evaluate the effects of
model assumptions and parameters on results. Specifically,
sensitivity analysis was performed for the peri-operative mortality
rate, age of diagnosis and gender. A threshold value was
calculated in cases for which a change in the preferred strategy was
traversed.
Results
Studies used in the analysis are shown in Tables 1 and 2 for the
group undergoing simple cholecystectomy alone and the group
undergoing radical cholecystectomy, respectively. Overall, a total
of 18 studies including 157 patients and 7 studies including 40
patients were used to calculate baseline probabilities for the
simple- and radical cholecystectomy groups, respectively. For the
simple cholecystectomy alone group, we calculated a weighted
mean 5-year cancer-specific survival of 61.3%. For those patients
undergoing radical resection we obtained a mean 5-year survival
of 87.5% (Table 4).Weighted peri-operative mortality was slightly
less than 2% (Tables 3 and 4). For those 40 patients having a
radical cholecystectomy, we calculated a weighted probability of
lymph node metastases to be 2.5%.
Our Markov model (shown in Fig. 3) demonstrates the two
potential treatment arms: radical resection vs. no additional
surgery. Patients in the radical resection group were faced with an
initial potential for a peri-operative death. Patients in both groups
faced potential cancer-specific mortality each year after diagnosis.
And finally, patients in both groups were subject to non-cancer-
related mortalities.
For our cohort of patients, the base-case decision analysis
favoured radical resection over simple cholecystectomy without
additional surgery. Life-expectancy after simple cholecystectomy
alone was 6.42 years after diagnosis. In contrast, radical resection
improved life-expectancy to 9.85 years after diagnosis, providing
an additional 3.43 years survival benefit over simple cholecystec-
tomy alone.
Sensitivity analysis
One-way sensitivity analyses in which the age-at-diagnosis was
varied is shown in Fig. 4. Varying the age from 20 to 100 years at
the time of diagnosis demonstrated that the greatest benefit from
radical resection in terms of gained life-years was achieved when
the diagnosis was made at a young age.
For all ages, men had a slightly decreased survival benefit com-
pared with females, likely secondary to their slightly shorter
overall life expectancy (Table 5).
The decision to perform a radical resection for T1b gallbladder
cancer over a simple cholecystectomy is sensitive to the periop-
erative mortality rate. When the probability of peri-operative
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Figure 3 Decision tree for treatment of patients with incidentally
discovered T1b gallbladder cancer after routine cholecystectomy.
Therapeutic strategies are shown after decision node (to right of ).
Probabilistic outcome is shown after chance node (to the right of ).
Terminal nodes signify death (D) or that Markov model defines
ensuing pathway (M). OR, operating room
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Figure 4 One-way sensitivity analysis varying the age at diagnosis
from 20 to 100 years. The greatest benefit in terms of gained life-
years was achieved for the youngest ages having radical resection,
with this benefit gradually decreasing with increasing age of the
patient subset. OR, operating room
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mortality is36% (intersection of the lines in Fig. 5) the analysis
favours treatment with simple cholecystectomy alone over radical
resection.
Discussion
Radical gallbladder resection in the management of T1b gallblad-
der cancers is controversial. Despite the fact that radical resection
for these patients is recommended by many hepatobiliary sur-
geons, a recently published administrative database study suggests
that less than 5% of patients with T1b gallbladder cancer in the
United States currently undergo radical resection.18
In our analysis, we demonstrated increased long-term survival
for patients with T1b gallbladder cancer who undergo radical
resection vs. those treated with simple cholecystectomy alone.
This finding is robust (note the high threshold value for peri-
operative mortality rate on sensitivity analysis) and valid over a
wide range of patient age at which gallbladder cancer is diagnosed.
Prior analysis of outcomes associated with T1b gallbladder
cancer have been limited to small single institution series.9,23 Two
analyses of the Surveillance, Epidemiology, and End Results
(SEER) registry database for gallbladder cancer have been
reported; however, in neither report were outcomes associated
with simple cholecystectomy vs. radical resection compared spe-
cifically for patients with T1b lesions.18,24
A decision analysis study, such as ours, is not without potential
limitations, which we enumerate here. In addition to the limited
number of published studies that met inclusion criteria for our
analysis (as noted above), we are using published data from mul-
tiple different authors and institutions which has lead to variabil-
ity in the pooled data. For example, there were variations in the
specific surgical procedures performed between (and even within)
studies. In the simple cholecystectomy group, some patients had
open cholecystecomy performed whereas others had laparoscopic
procedures. However, we do not believe this variability adversely
affects our results to a great extent as data from previously pub-
lished studies indicates no survival difference between treatment
with conventional open procedure vs. laparoscopic surgery for
those patients with early gallbladder cancer.25–27 Ouchi et al., for
example, found little difference upon comparing outcomes data
from 498 patients with gallbladder cancer treated laparoscopically
to their survival data from standard open procedures.27 They
determined that laparoscopic cholecystectomy did not have any
adverse effects on the long-term outcomes of these patients.27
Similarly, in the radical cholecystectomy group, some patients
were treated with radical cholecystectomy during the initial
operation whereas others were ‘re-resected’ at a later date after an
initial simple cholecystectomy. Again, we do not believe this issue
affects our findings. Shih et al. determined that there was no
difference in survival between patients who were discovered to
have gallbladder cancer incidentally on laparoscopic cholecystec-
tomy and immediately converted to an open resection and those
Table 5 Age at diagnosis, gender and outcomes
Age at diagnosis Gender Procedure Life expectancy(years)
35 Male Simple cholecystectomy 9
Radical cholecystectomy 19
35 Female Simple cholecystectomy 9
Radical cholecystectomy 20
65 Male Simple cholecystectomy 7
Radical cholecystectomy 11
65 Female Simple cholecystectomy 7
Radical cholecystectomy 12
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Figure 5 One-way sensitivity analysis varying probability of peri-
operative mortality. The decision to treat with radical cholecystec-
tomy vs. simple cholecystectomy is sensitive to varying the
peri-operative mortality. Once peri-operative mortality reaches a
threshold of 36% (intersection of the two lines in the graph) the
analysis favours no further surgery over radical resection. OR, oper-
ating room
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who had a completed laparoscopic cholecystectomy and were
re-explored at a later point when found to have gallbladder cancer
by subsequent pathology.28
Additional shortcoming of our analysis include an inability
(because of a lack of published data) to stratify survival data based
on resectionmargin status, lymph node involvement and adjuvant
therapy. Furthermore, the findings from this study, while useful
on a population basis, do not take into account individual patient
characteristics (e.g. co-morbidities, medications, family history),
nor individual patient wishes for treatment. It must be reiterated,
as such, that decisions to treat with one modality vs. another need
to be made on a case-by-case basis taking into account all relevant
factors.
In conclusion, decision analysis based on data available for the
subset of patients with T1b gallbladder cancer demonstrates that
radical cholecystectomy is associated with improved survival for
most patients with T1b gallbladder cancer.
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